Pharma's New Worldview: Transforming R&D through Emerging Markets

Pharma's New Worldview: Transforming R&D through Emerging Markets

Large pharma companies consider R&D such a defining capability, they've been hesitant to move these activities outside the firm-much less offshore. This paper addresses new market forces that are compelling them to consider a range of alternatives, including outsourcing and offshore opportunities.


Heather Fraser Global Leader for the Life Sciences / Pharma Team at the IBM Institute for Business Value, IBM Heather Fraser is a pharmacist with over 20 years of industry experience and has held positions within R&D, consultancy and community pharmacy. She is currently the global leader for the Life Sciences / Pharma team at the IBM Institute for Business Value. Heather has published a variety of articles on pharmaceutical industry issues in publications such as Pharmaceutical Technology, GCP Journal, PharmaFocus Asia, Biopartnering Today and Financier Worldwide Biotechnology Review.
Isabelle Pontille Global Learning and Knowledge Manager, IBM Isabelle Pontille has over 18 years experience working across various industries in both Western and Eastern Europe, having been based in Poland for 8 years. As a management consultant, her experience in the pharma sector includes extensive work around timeto- market and commercial strategy, in both developed and emerging markets. She has been invited to speak at a number of industry conferences, including the opening session of a conference in Warsaw about Polish Health reform. Isabelle now works as a Global Learning and Knowledge Manager for IBM.
IBM Line of Business
27 Feb 2008
01 Oct 2006
20 Page(s)
White Paper
Already a Bitpipe member? Login here

Download this White Paper!

By submitting your personal information, you agree that TechTarget and its partners may contact you regarding relevant content, products and special offers.

You also agree that your personal information may be transferred and processed in the United States, and that you have read and agree to the Terms of Use and the Privacy Policy.